Job alert🚨 Postdoc (Computational Proteomics × Plant Immunity) 🌱 Join us to build a cross-species plant pan-terminome & study proteolysis in immunity with excellent collaborators: Bernhard Kuester, Mathias Wilhelm, @degradomics.bsky.social, Patrick Willems, @patrickbryant1.bsky.social Please RT 🙏

Introducing The Structural History of Eukarya (SHE): The first proteome-scale phylogeny constructed entirely from 3D structure. We computed 300 trillion alignments across 1,542 species to map the tree of life. 🧵👇 (1/5)

The future of drug design is in AI. RareFoldGPCR: Agonist Design Beyond Natural Amino Acids. Paper: www.biorxiv.org/content/10.1... Code: github.com/patrickbryan...

Update: RareFold 🧬 Our AI framework for protein design with 29 noncanonical AAs now shows designed binders (linear + cyclic) are non-immunogenic in patient-derived assays — paving the way for safe next-gen peptide therapeutics. 👉https://www.biorxiv.org/content/10.1101/2025.05.19.654846v2

RareFold: Structure prediction and design of proteins with noncanonical amino acids

Protein structure prediction and design have traditionally been limited to the 20 canonicalamino acids. Expanding this space to include noncanonical amino acids (NCAAs) offers newopportunities for pro...

biorxiv.org

Our study where we develop EvoBind2: Design of linear and cyclic peptide binders from protein sequence information is now published! www.nature.com/articles/s42...

Cool! Congrats @proteinator.bsky.social 🎉

Seva Viliuga@proteinator.bsky.social · last yr.

1/6 One of the key features of functional proteins is their inherent structural flexibility. In our recent work at #ICML, we introduce flexibility to protein structure design! More in a thread below. Code / Tutorial: github.com/graeter-grou... Poster: W-109, Thu 17 Jul 11 a.m. PDT — 1:30 p.m. PDT

Now published: our study on human-pathogen protein-protein interactions! We identify 30 interactions with an expected TM-score ≥0.9, tripling the structural coverage in these networks. One novel interaction was validated with mass spectrometry. journals.plos.org/ploscompbiol...

Our latest work is out: we designed dual GLP1R/GCGR agonists—cyclic peptides that activate both metabolic receptors, entirely from sequence alone. This has never been done before. www.biorxiv.org/content/10.1...

You can also design in Colab now: colab.research.google.com/github/patri...

Google Colab

colab.research.google.com

Patrick Bryant@patrickbryant1.bsky.social · last yr.

Happy to release our breakthrough AI-model: RareFold, which predicts and designs proteins with noncanonical AAs. With EvoBindRare, we designed linear & cyclic peptide binders with high affinity & novel binding modes, wet lab validated. 📄 biorxiv.org/content/10.1... 💻 github.com/patrickbryan...

Happy to release our breakthrough AI-model: RareFold, which predicts and designs proteins with noncanonical AAs. With EvoBindRare, we designed linear & cyclic peptide binders with high affinity & novel binding modes, wet lab validated. 📄 biorxiv.org/content/10.1... 💻 github.com/patrickbryan...